1-6 of 6
Arlene A. Forastiere
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303

Free
Ann Marie Egloff, Ju-Whei Lee, Corey J. Langer, Harry Quon, Alec Vaezi, Jennifer R. Grandis, Raja R. Seethala, Lin Wang, Dong M. Shin, Athanassios Argiris, Donghua Yang, Ranee Mehra, John Andrew Ridge, Urjeet A. Patel, Barbara A. Burtness, Arlene A. Forastiere
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (19): 5041–5051.
https://doi.org/10.1158/1078-0432.CCR-14-0051
Published: 30 September 2014
View articletitled, Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303
Open the PDF for Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303 in another window
Includes: Supplementary data
Journal Articles

Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303

Free
Amanda Psyrri, Ju-Whei Lee, Eirini Pectasides, Maria Vassilakopoulou, Efstratios K. Kosmidis, Barbara A. Burtness, David L. Rimm, Harold J. Wanebo, Arlene A. Forastiere
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (11): 3023–3032.
https://doi.org/10.1158/1078-0432.CCR-14-0113
Published: 29 May 2014
View articletitled, Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303
Open the PDF for Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303 in another window
Includes: Supplementary data
Journal Articles

Clinical Correlates of Promoter Hypermethylation of Four Target Genes in Head and Neck Cancer: A Cooperative Group Correlative Study

Free
Jong-Lyel Roh, Xin Victoria Wang, Judith Manola, David Sidransky, Arlene A. Forastiere, Wayne M. Koch
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (9): 2528–2540.
https://doi.org/10.1158/1078-0432.CCR-12-3047
Published: 30 April 2013
View articletitled, Clinical Correlates of Promoter Hypermethylation of Four Target Genes in Head and Neck Cancer: A Cooperative Group Correlative Study
Open the PDF for Clinical Correlates of Promoter Hypermethylation of Four Target Genes in Head and Neck Cancer: A Cooperative Group Correlative Study in another window
Journal Articles

Prognostic Importance of Promoter Hypermethylation of Multiple Genes in Esophageal Adenocarcinoma

Free
Malcolm V. Brock, Mingzhou Gou, Yoshimitsu Akiyama, Alison Muller, Tsung-Teh Wu, Elizabeth Montgomery, Mari Deasel, Paul Germonpré, Lewis Rubinson, Richard F. Heitmiller, Stephen C. Yang, Arlene A. Forastiere, Stephen B. Baylin, James G. Herman
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (8): 2912–2919.
Published: 11 August 2003
View articletitled, Prognostic Importance of Promoter Hypermethylation of Multiple Genes in Esophageal Adenocarcinoma
Open the PDF for Prognostic Importance of Promoter Hypermethylation of Multiple Genes in Esophageal Adenocarcinoma in another window
Journal Articles

Frequent Hypermethylation of the 5′ CpG Island of E-Cadherin in Esophageal Adenocarcinoma

Free
Paul G. Corn, Elisabeth I. Heath, Richard Heitmiller, Franz Fogt, Arlene A. Forastiere, James G. Herman, Tsung-Teh Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (9): 2765–2769.
Published: 01 September 2001
View articletitled, Frequent Hypermethylation of the 5′ CpG Island of E-Cadherin in Esophageal Adenocarcinoma
Open the PDF for Frequent Hypermethylation of the 5′ CpG Island of E-Cadherin in Esophageal Adenocarcinoma in another window
Journal Articles

Prognostic Value of p53, Glutathione S-Transferase π, and Thymidylate Synthase for Neoadjuvant Cisplatin-based Chemotherapy in Head and Neck Cancer

Free
Hideaki Shiga, Elizabeth I. Heath, Audrey A. Rasmussen, Bruce Trock, Patrick G. Johnston, Arlene A. Forastiere, Miles Langmacher, Alfred Baylor, Michele Lee, Kevin J. Cullen
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 4097–4104.
Published: 01 December 1999
View articletitled, Prognostic Value of p53, Glutathione S-Transferase π, and Thymidylate Synthase for Neoadjuvant Cisplatin-based Chemotherapy in Head and Neck Cancer
Open the PDF for Prognostic Value of p53, Glutathione S-Transferase π, and Thymidylate Synthase for Neoadjuvant Cisplatin-based Chemotherapy in Head and Neck Cancer in another window